Paper972697
Mechanisms of bone destruction in the development of skeletal metastases.
Galasko CS. Nature, 1976. Cited by 261 papers, by iCite.
Cite this record
ConductScience Library. Mechanisms of bone destruction in the development of skeletal metastases. Papers, record 972697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/972697
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bone Neoplasms | Major topic |
| Bone Resorption | Major topic |
| Osteoclasts | Major topic |
| Animals | |
| Cell Division | |
| Humans | |
| Neoplasm Metastasis | |
| Neoplasms, Experimental | |
| Rabbits |
Source PubMed
Cited by43
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 261 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33900965 | Features of Spinal Metastases: A Retrospective View. | Int J Spine Surg | 2021 | https://conductscience.org/library/papers/33900965 | PubMed |
| 31578655 | Harnessing the versatile role of OPG in bone oncology: counterbalancing RANKL and TRAIL signaling and beyond. | Clin Exp Metastasis | 2020 | https://conductscience.org/library/papers/31578655 | PubMed |
| 24573404 | Establishment of successively transplantable rabbit VX2 cancer cells that express enhanced green fluorescent protein. | Med Mol Morphol | 2015 | https://conductscience.org/library/papers/24573404 | PubMed |
| 24448976 | Nuclear factor-kappa B ligand and osteoprotegerin levels in serum and gingival crevicular fluid in patients with bone metastases treated with zoledronic acid. | Med Oncol | 2014 | https://conductscience.org/library/papers/24448976 | PubMed |
| 22312491 | Physiopathology of spine metastasis. | Int J Surg Oncol | 2011 | https://conductscience.org/library/papers/22312491 | PubMed |
| 19050684 | Molecular mechanisms of metastasis in prostate cancer. | Asian J Androl | 2009 | https://conductscience.org/library/papers/19050684 | PubMed |
| 18057140 | Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease. | Endocr Rev | 2008 | https://conductscience.org/library/papers/18057140 | PubMed |
| 16641914 | Malignant melanoma and bone resorption. | Br J Cancer | 2006 | https://conductscience.org/library/papers/16641914 | PubMed |
| 16542503 | Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026]. | Breast Cancer Res | 2006 | https://conductscience.org/library/papers/16542503 | PubMed |
| 15988801 | Efficacy of oral etidronate for skeletal diseases in Japan. | Yonsei Med J | 2005 | https://conductscience.org/library/papers/15988801 | PubMed |
| 12498385 | A murine model of bone marrow micrometastasis in breast cancer. | Clin Exp Metastasis | 2002 | https://conductscience.org/library/papers/12498385 | PubMed |
| 11091506 | Parathyroid Hormone-related Protein in Breast Cancer Tissues: Relationship between Primary and Metastatic Sites. | Breast Cancer | 1994 | https://conductscience.org/library/papers/11091506 | PubMed |
| 10998677 | Neurophysiology of Cancer Pain: From the Laboratory to the Clinic. | Curr Rev Pain | 1999 | https://conductscience.org/library/papers/10998677 | PubMed |
| 9152972 | Utility of bisphosphonates in treating bone metastases. | Med Oncol | 1996 | https://conductscience.org/library/papers/9152972 | PubMed |
| 8698861 | Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro. | J Clin Invest | 1996 | https://conductscience.org/library/papers/8698861 | PubMed |
| 8375111 | Hypercalcemia in breast cancer. | Clin Exp Metastasis | 1993 | https://conductscience.org/library/papers/8375111 | PubMed |
| 8143097 | Hypercalcaemia: historical perspectives and present management. | Support Care Cancer | 1993 | https://conductscience.org/library/papers/8143097 | PubMed |
| 8003863 | The expression of parathyroid hormone-related protein in human breast cancer with skeletal metastases. | Surg Today | 1994 | https://conductscience.org/library/papers/8003863 | PubMed |
| 7773580 | The management of hypercalcemia of malignancy. | Support Care Cancer | 1995 | https://conductscience.org/library/papers/7773580 | PubMed |
| 7734300 | Type I collagen degradation product (ICTP) gives information about the nature of bone metastases and has prognostic value in prostate cancer. | Br J Cancer | 1995 | https://conductscience.org/library/papers/7734300 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/972697
GET https://conductscience.org/api/papers/v1/972697/cited_by?page=2